
51 - 200 employees
Founded 2005
🧬 Biotechnology
đź’Š Pharmaceuticals
🔬 Science
Biotechnology • Pharmaceuticals • Science
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company developing cell- and exosome-based therapeutics, focused on precision medicine for Duchenne muscular dystrophy and other serious diseases. The company advances allogeneic cardiosphere-derived cells (CDCs) and exosome platforms across a multi-stage pipeline, including investigational cell therapy (deramiocel) and approaches for loading therapeutic oligonucleotides into exosomes. Capricor emphasizes patient-focused development, translational research, and strategic partnerships to bring novel biologic medicines to patients.
đź•’ June 2
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2005
🧬 Biotechnology
đź’Š Pharmaceuticals
🔬 Science
Biotechnology • Pharmaceuticals • Science
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company developing cell- and exosome-based therapeutics, focused on precision medicine for Duchenne muscular dystrophy and other serious diseases. The company advances allogeneic cardiosphere-derived cells (CDCs) and exosome platforms across a multi-stage pipeline, including investigational cell therapy (deramiocel) and approaches for loading therapeutic oligonucleotides into exosomes. Capricor emphasizes patient-focused development, translational research, and strategic partnerships to bring novel biologic medicines to patients.
• Develop and execute the territory KOL/HCP engagement plan, including identification, mapping, and prioritization of thought leaders, prescribers and treatment centers.**• Deliver scientific presentations and engage in scientific exchange with KOLs and HCPs on Deramiocel clinical data, the DMD cardiomyopathy landscape, and emerging evidence.**• Support advisory boards, scientific symposia, and KOL-led research initiatives.**• Identify and support investigator-initiated studies (IIS) and real-world evidence opportunities in coordination with HEOR / RWE and Medical Director.**• Provide scientific support for medical congresses, including DMD, neuromuscular, cardiology, and rare-disease forums.**• Collect and synthesize field insights on clinical practice, treatment decision-making, and emerging evidence; translate insights into recommendations for medical strategy.**• Provide scientific training and support to internal stakeholders (Sales, Market Access, Patient Services) in compliance with channel and engagement rules.**• Maintain comprehensive scientific fluency on Deramiocel clinical data, DMD natural history, and the broader treatment landscape.**• Ensure timely reporting of adverse events and product complaints in line with company and regulatory processes.**• Document field activities, KOL/HCP engagement, and insights in Capricor's medical CRM in compliance with standards.**• Ensure all activities follow FDA, OIG, PhRMA Code, ACCME, and Capricor compliance standards.**• Perform other duties as may be assigned from time to time.
• Advanced clinical degree required (MD, PharmD, PhD, DO, or equivalent).**• 5 to 10 years of MSL experience in biotech / pharma; experience in rare disease, cell / gene therapy, pediatrics, neuromuscular disease, or cardiology preferred.**• Established scientific credibility and ability to engage KOLs in peer-to-peer scientific exchange.**• Strong working knowledge of FDA, OIG, PhRMA Code, ACCME, and MLR review processes.**• Excellent written and verbal scientific communication skills, including ability to deliver complex data to clinical audiences.**• Self-directed execution and the ability to operate independently in a field-based environment.
• Collaborative environment for professional growth and innovation
Apply Nowđź•’ June 2
Director of Strategic Transactions for global M&A transactions at Ciena. Collaborating with leadership to execute strategic acquisitions and partnerships.
🇺🇸 United States – Remote
đź’° Series C on 1995-12
⏰ Full Time
đź”´ Lead
đź‘” Director
🦅 H1B Visa Sponsor
đź•’ June 2
Director of Consumer overseeing charity: water's recurring giving growth and managing paid media strategies. Leading donor engagement and maximizing financial contributions to support clean water initiatives.
đź•’ June 2
Director responsible for driving commercial growth and shaping software compliance advisory services. Leading strategic client relationships within a specialist advisory firm.
đź•’ June 2
ASDC Regional Director responsible for supporting and coaching State Party leaders across the Western region. Fostering communication and building Democratic infrastructure for successful coordination.
đź•’ June 2
Director driving manufacturing strategy and transformation for ERMCO, leading modernization initiatives and enhancing supply chain capabilities. Collaborating with executives to align operational growth and efficiency.